Arcoma AB Total Assets
Arcoma AB total assets. Based on the latest financial reports, Arcoma AB (ARCOMA) holds total assets worth Skr101.84 Million SEK (≈ $10.96 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Arcoma AB worth for the company's overall valuation and market capitalisation.
Total Assets of Arcoma AB (2012–2025)
Total assets of Arcoma AB from 2012 to 2025. This chart illustrates how Arcoma AB's total assets have evolved over time, based on quarterly financial data. See Arcoma AB stock quote for real-time trading data and today's change.
Arcoma AB - Asset Composition Analysis
Arcoma AB Total Assets Breakdown (December 2025)
Arcoma AB total assets breakdown as of December 2025. Arcoma AB's total assets of Skr101.84 Million consist of 79.2% current assets and 20.8% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 36.5% |
| Accounts Receivable | Skr17.62 Million | 18.2% |
| Inventory | Skr23.63 Million | 24.5% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr16.78 Million | 17.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Arcoma AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Arcoma AB to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arcoma AB's current assets represent 79.2% of total assets in 2025, an increase from 67.3% in 2012.
- Cash Position: Cash and equivalents constituted 36.5% of total assets in 2025, up from 0.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, a decrease from 21.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 24.5% of total assets.
Arcoma AB Competitors by Total Assets
Key competitors of Arcoma AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Arcoma AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.12 | 2.25 | 1.67 |
| Quick Ratio | 2.14 | 1.24 | 0.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr55.70 Million | Skr38.49 Million | Skr24.34 Million |
Arcoma AB - Advanced Valuation Insights
This section examines the relationship between Arcoma AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.62 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 20.1% |
| Total Assets | Skr96.65 Million |
| Market Capitalization | $13.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arcoma AB's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Arcoma AB's assets grew by 20.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Arcoma AB (2012–2025)
The table below shows the annual total assets of Arcoma AB from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr96.65 Million ≈ $10.40 Million |
+20.12% |
| 2024-12-31 | Skr80.46 Million ≈ $8.66 Million |
-1.83% |
| 2023-12-31 | Skr81.96 Million ≈ $8.82 Million |
-18.31% |
| 2022-12-31 | Skr100.33 Million ≈ $10.80 Million |
+26.57% |
| 2021-12-31 | Skr79.27 Million ≈ $8.53 Million |
-16.59% |
| 2020-12-31 | Skr95.03 Million ≈ $10.23 Million |
+14.04% |
| 2019-12-31 | Skr83.33 Million ≈ $8.97 Million |
+9.25% |
| 2018-12-31 | Skr76.27 Million ≈ $8.21 Million |
+11.98% |
| 2017-12-31 | Skr68.11 Million ≈ $7.33 Million |
-4.41% |
| 2016-12-31 | Skr71.25 Million ≈ $7.67 Million |
-15.43% |
| 2015-12-31 | Skr84.25 Million ≈ $9.07 Million |
+6.37% |
| 2014-12-31 | Skr79.21 Million ≈ $8.52 Million |
+11.77% |
| 2013-12-31 | Skr70.87 Million ≈ $7.63 Million |
+3.47% |
| 2012-12-31 | Skr68.49 Million ≈ $7.37 Million |
-- |
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more